Structural plasticity of the proteasome and its function in antigen processing
- PMID: 11922078
Structural plasticity of the proteasome and its function in antigen processing
Abstract
The proteasome is the main provider of peptide ligands for major histocompatibility complex class I molecules. During an immune response to pathogens, the proinflammatory cytokine interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha are released, which induce the proteasome subunits LMP2, LMP7, and MECL-1. These replace the constitutively expressed active site subunits of the proteasome (delta, MB1, and Z) leading to a marked change in the cleavage preference of the proteasome and the production of T-cell epitopes. Proteasome activity is further changed by the IFN-gamma-mediated induction of the proteasome regulator PA28alpha/beta and the downregulation of PA28gamma. Why such an extensive exchange of proteasome active site subunits and regulators occurs is still poorly understood. In this article we discuss recent insights in the structural consequences of proteasome reorganization and their effects on epitope generation and shaping of the cytotoxic immune response. Moreover, we review the latest data on how the ubiquitin pathway targets protein antigens for peptide processing and discuss the potential of proteasome inhibitors for the modulation of antigen presentation.
Similar articles
-
Biochemical analysis of proteasomes from mouse microglia: induction of immunoproteasomes by interferon-gamma and lipopolysaccharide.Glia. 2000 Feb 15;29(4):355-65. Glia. 2000. PMID: 10652445
-
The role of the proteasome system and the proteasome activator PA28 complex in the cellular immune response.Biol Chem. 1999 Mar;380(3):293-7. doi: 10.1515/BC.1999.040. Biol Chem. 1999. PMID: 10223331 Review.
-
A third interferon-gamma-induced subunit exchange in the 20S proteasome.Eur J Immunol. 1996 Apr;26(4):863-9. doi: 10.1002/eji.1830260421. Eur J Immunol. 1996. PMID: 8625980
-
The proteasome activator 11 S REG (PA28) and class I antigen presentation.Biochem J. 2000 Jan 1;345 Pt 1(Pt 1):1-15. Biochem J. 2000. PMID: 10600633 Free PMC article. Review.
-
A role for the proteasome regulator PA28alpha in antigen presentation.Nature. 1996 May 9;381(6578):166-8. doi: 10.1038/381166a0. Nature. 1996. PMID: 8610016
Cited by
-
Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis.Arthritis Res Ther. 2006;8(4):R105. doi: 10.1186/ar1990. Arthritis Res Ther. 2006. PMID: 16817978 Free PMC article.
-
Gamma interferon and monophosphoryl lipid A-trehalose dicorynomycolate are efficient adjuvants for Mycobacterium tuberculosis multivalent acellular vaccine.Infect Immun. 2005 Jan;73(1):250-7. doi: 10.1128/IAI.73.1.250-257.2005. Infect Immun. 2005. PMID: 15618161 Free PMC article.
-
Tumor-derived autophagosome vaccine: mechanism of cross-presentation and therapeutic efficacy.Clin Cancer Res. 2011 Nov 15;17(22):7047-57. doi: 10.1158/1078-0432.CCR-11-0951. Epub 2011 Nov 8. Clin Cancer Res. 2011. PMID: 22068657 Free PMC article.
-
Stable antigen is most effective for eliciting CD8+ T-cell responses after DNA vaccination and infection with recombinant vaccinia virus in vivo.J Virol. 2012 Sep;86(18):9782-93. doi: 10.1128/JVI.00694-12. Epub 2012 Jul 3. J Virol. 2012. PMID: 22761378 Free PMC article.
-
Proteomic expression analysis of surgical human colorectal cancer tissues: up-regulation of PSB7, PRDX1, and SRP9 and hypoxic adaptation in cancer.J Proteome Res. 2008 Jul;7(7):2959-72. doi: 10.1021/pr8000892. Epub 2008 Jun 13. J Proteome Res. 2008. PMID: 18549262 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous